Table of Contents Author Guidelines Submit a Manuscript
E-Journal of Chemistry
Volume 5, Issue 3, Pages 515-520
http://dx.doi.org/10.1155/2008/827984

Spectrophotometric Determination of Gemifloxacin Mesylate in Pharmaceutical Formulations Through Ion-Pair Complex Formation

Marothu Vamsi Krishna and Dannana Gowri Sankar

Pharmaceutical Analysis and Quality Assurance Division, College of Pharmaceutical Sciences, Andhra University, Visakhapatnam, India

Received 20 April 2007; Accepted 10 June 2007

Copyright © 2008 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [28 citations]

The following is the list of published articles that have cited the current article.

  • R. Rote Ambadas, and P. Pingle Sunita, “Validated UV-Spectrophotometric Methods for Determination of Gemifloxacin Mesylate in Pharmaceutical Tablet Dosage Forms,” E-Journal Of Chemistry, vol. 7, pp. S344–S348, 2010. View at Publisher · View at Google Scholar
  • Yunoos Mohammad, Azmath Hussain, Harish Harish, and B. Pragati Kumar, “Development and Validation of RP-HPLC Method for the Estimation of Gemiflox acin Mesylate in Bulk and Pharmaceutical Dosage Forms,” E-Journal Of Chemistry, vol. 7, no. 4, pp. 1621–1627, 2010. View at Publisher · View at Google Scholar
  • Serife Evrim Kepekci Tekkeli, and Armagan Onal, “Spectrofluorimetric Methods for the Determination of Gemifloxacin in Tablets and Spiked Plasma Samples,” Journal Of Fluorescence, vol. 21, no. 3, pp. 1001–1007, 2011. View at Publisher · View at Google Scholar
  • S. Sharif, I. U. Khan, T. A. Sheikh, Y. Sharif, and M. Ashfaq, “Validated Stability-Indicating HPLC Method for Analysis of Gemifloxacin in Tablet Formulations,” Acta Chromatographica, vol. 23, no. 1, pp. 95–107, 2011. View at Publisher · View at Google Scholar
  • Clésio S. Paim, Fernanda Führ, Aline B. Barth, Carlos E.I. Gonçalves, Nance Nardi, Martin Steppe, and Elfrides E.S. Schapoval, “Gemifloxacin mesylate (GFM) stability evaluation applying a validated bioassay method and in vitro cytotoxic study,” Talanta, vol. 83, no. 5, pp. 1774–1779, 2011. View at Publisher · View at Google Scholar
  • Sara A.M. Ebraheem, Abdalla A. Elbashir, and Hassan Y. Aboul-Enein, “Spectrophotometric methods for the determination of gemifloxacin in pharmaceutical formulations,” Acta Pharmaceutica Sinica B, vol. 1, no. 4, pp. 248–253, 2011. View at Publisher · View at Google Scholar
  • Moacir Kaiser, Lauren D. Gruenspan, Teresa Dalla Costa, and Leandro Tasso, “Reversed phase liquid chromatography method with fluorescence detection of gemifloxacin in rat plasma and its application to the pharmacokinetic study,” Journal Of Chromatography B-Analytical Technologies In The Biomedical And L, vol. 879, no. 30, pp. 3639–3644, 2011. View at Publisher · View at Google Scholar
  • Najma Sultana, M. Saeed Arayne, Sana Shamim, and Asia Naz, “Validated Method for the Simultaneous Determination of Gemifloxacin and H2-receptor Antagonists in Bulk, Pharmaceutical Formulations and Human Serum by RP-HPLC; In-vitro Applications,” Journal of the Chinese Chemical Society, vol. 58, no. 5, pp. 629–636, 2011. View at Publisher · View at Google Scholar
  • Fang Zhao, Wen-hui Zhao, and Wei Xiong, “Chemiluminescence determination of gemifloxacin based on diperiodatoargentate (III)-sulphuric acid reaction in a micellar medium,” Luminescence, vol. 28, no. 2, pp. 108–113, 2012. View at Publisher · View at Google Scholar
  • Satyabrata Sahu, Saroj Kumar Patro, Una Laxmi Narayan, and Bamakanta Garnaik, “Ion-pair spectrophotometric estimation of gemifloxacin,” Pharmaceutical Methods, vol. 3, no. 1, pp. 26–30, 2012. View at Publisher · View at Google Scholar
  • Fernanda Fuehr, Clesio Soldateli Paim, Martin Steppe, and Elfrides Eva Scherman Schapoval, “Gemifloxacin Mesylate: Uv Spectrophotometric Method For Quantitative Determ Ination Using Experimental Design For Robustness,” Quimica Nova, vol. 35, no. 1, pp. 193–197, 2012. View at Publisher · View at Google Scholar
  • Salma Ali Al-Tamimi, Nawal Ahmad Alarfaj, Fatma Ahmed Aly, and Amal Mohammed Al-Mohaimeed, “Spectrofluorimetric analysis of gemifloxacin mesylate in pharmaceutical formulations,” Luminescence, 2013. View at Publisher · View at Google Scholar
  • Abd-Elgawad Radi, Amira Khafagy, Amira El-shobaky, and Hatem El-mezayen, “Anodic Voltammetric determination of gemifloxacin using screen-printed carbon electrode,” Journal of Pharmaceutical Analysis, vol. 3, no. 2, pp. 132–136, 2013. View at Publisher · View at Google Scholar
  • Akram M. EL-Didamony, and Mona O. Abo-Elsoad, “Kinetic spectrophotometric method for the determination of some fourth generation fluoroquinolones in bulk and in pharmaceutical formulations,” Journal of Saudi Chemical Society, 2013. View at Publisher · View at Google Scholar
  • Salma Ali Al-Tamimi, “Spectrophotometric and spectrofluorimetric methods for the determination of gemifloxacin mesylate in its pure and dosage forms using eosin,” Asian Journal of Chemistry, vol. 25, no. 16, pp. 9272–9276, 2013. View at Publisher · View at Google Scholar
  • Noha N. Atia, Ashraf M. Mahmoud, Salwa R. El-Shabouri, and Wesam M. El-Koussi, “Two Validated Spectrofluorometric Methods for Determination of Gemifloxacin Mesylate in Tablets and Human Plasma,” International Journal of Analytical Chemistry, 2013. View at Publisher · View at Google Scholar
  • Adnan A. Kadi, Rihab F. Angawi, Mohamed W. Attwa, Hany W. Darwish, and Ali Saber Abdelhameed, “High Throughput Quantitative Bioanalytical LC/MS/MS Determination of Gemifloxacin in Human Urine,” Journal of Chemistry, 2013. View at Publisher · View at Google Scholar
  • Mohammed G. Abdel Wahed, Ragaa El Sheikh, Ayman A. Gouda, and Sayed Abou Taleb, “Kinetic Spectrophotometric Determination Of Some Fluoroquinolone Antibiotics In Bulk And Pharmaceutical Preparations,” Bulletin of The Chemical Society of Ethiopia, vol. 27, no. 3, pp. 329–346, 2013. View at Publisher · View at Google Scholar
  • Namasani Santhosh Kumar, Avula Prameela Rani, Telu Visalakshi, and Chandra Bala Sekaran, “Extractive spectrophotometric determination of ambrisentan,” Advanced Pharmaceutical Bulletin, vol. 3, no. 1, pp. 231–237, 2013. View at Publisher · View at Google Scholar
  • Clésio Soldateli Paim, Bibiana Verlindo de Araújo, Nádia Maria Volpato, Martin Steppe, and Elfrides Eva Sherman Schapoval, “ Gemifloxacin mesylate (GFM): dissolution test based on in vivo data ,” Drug Development and Industrial Pharmacy, pp. 1–6, 2014. View at Publisher · View at Google Scholar
  • Clesio S. Paim, Fernanda Fuehr, Diogo S. Miron, Martin Steppe, and Elfrides E. S. Schapoval, “Highly Selective Colorimetric Method to Determine Gemifloxacin Mesylate in the Presence of a Synthetic Impurity,” Journal of Aoac International, vol. 97, no. 1, pp. 94–98, 2014. View at Publisher · View at Google Scholar
  • Attia, Abd-Elaleem, Abd-Elhamid, Abd-Elmoety, and Badawy, “Electroanalytical determination of gemifloxacin mesylate in bulk, tablets and human urine using gold nanoparticles modified carbon paste electrode,” Analytical and Bioanalytical Chemistry Research, vol. 1, no. 2, pp. 128–138, 2014. View at Publisher · View at Google Scholar
  • Ayman A. Gouda, Alaa S. Amin, Ragaa El-Sheikh, and Amira G. Yousef, “Spectrophotometric Determination of Gemifloxacin Mesylate, Moxifloxacin Hydrochloride, and Enrofloxacin in Pharmaceutical Formulations Using Acid Dyes,” Journal of Analytical Methods in Chemistry, 2014. View at Publisher · View at Google Scholar
  • Mohammed G. Abdel Wahed, Ragaa El Sheikh, Ayman A. Gouda, and Sayed Abou Taleb, “Kinetic Spectrophotometric Determination of Gemifloxacin Mesylate and Moxifloxacin Hydrochloride in Pharmaceutical Preparations Using 4-Chloro-7-nitrobenzo-2-oxa-1,3-diazole,” Journal of Spectroscopy, 2014. View at Publisher · View at Google Scholar
  • Clésio Soldateli Paim, Fernanda Führ, Vítor Todeschini, Martin Steppe, and Elfrides Eva Scherman Schapoval, “Simultaneous analysis of gemifloxacin mesylate and its main synthetic impurity by an optimized capillary zone electrophoretic method,” Analytical Methods, vol. 6, no. 6, pp. 1657, 2014. View at Publisher · View at Google Scholar
  • Clésio Soldateli Paim, Fernanda Führ, Magda Targa Martins, Simone Gnoatto, Lisiane Bajerski, Cássia Virginia Garcia, Martin Steppe, and Elfrides Eva Scherman Schapoval, “Structural elucidation of gemifloxacin mesylate degradation product,” Biomedical Chromatography, 2015. View at Publisher · View at Google Scholar
  • Nuha Fathi Ali Dsugi, Abdalla A. Elbashir, and Fakhr Eldin Osman Suliman, “Supramolecular interaction of gemifloxacin and hydroxyl propyl β-cyclodextrin spectroscopic characterization, molecular modeling and analytical application,” Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, vol. 151, pp. 360–367, 2015. View at Publisher · View at Google Scholar
  • Nehad A. Abdallah, Heba F. Ibhrahim, and Nayira H. Hegabe, “Comparative study of molecularly imprinted polymer and magnetic molecular imprinted nanoparticles as recognition sites for the potentiometric determination of gemifloxacin mesylate,” International Journal of Electrochemical Science, vol. 12, no. 11, pp. 10894–10910, 2017. View at Publisher · View at Google Scholar